RSD - Nothing Left To Chance

Whether you call it Reflex Sympathetic Dystrophy Syndrome or Chronic Regional Pain Syndrome - it's still a hideous soul-sucking disease.

29.5.06

Call to Action - American Pain Foundation

We need your help to generate Congressional support for the passage of H.R. 1020. This is an alert from the American Pain Foundation.

Dear Endorsers of the National Pain Care Policy Act,

By signing the Consensus Statement, your organization has joined with others to show strong support for the National Pain Care Policy Act of 2005 (H.R. 1020) and the pain issues it addresses. The American Pain Foundation and the Pain Care Forum in cooperation with Representative Mike Rogers (R-MI) are pleased to announce:

A Congressional Briefing
THE EPIDEMIC OF PAIN IN AMERICA
June 13, 2006
Noon to 1pm
Cannon House Office Building
Room 121

The purpose of the briefing is to educate Congress on the serious need for federal policy reform affecting pain management. It is critical to generate large Congressional attendance, in order to:

-Increase their awareness of pain as a major public health problem
-Provide an understanding of the extensive barriers to effective pain management
-Educate congress on the critical need to improve access to pain management treatment.
-Provide information about the serious need to increase healthcare professional pain management education
-Alert them to the impact of current pain policy
-Urge congressional support for research about the causes of and treatments for pain
-Increase co-sponsorship of H.R.1020, the National Pain Care Policy Act

This is our opportunity to EDUCATE CONGRESS ON THE TRAGIC PERSONAL AND ECONOMIC EFFECTS OF THE UNDERTREATMENT OF PAIN!

TAKE ACTION NOW!
Contact your Congressional representatives and encourage them to attend this hearing. Please send email to your membership and professional network today and urge them to contact their representative about this briefing. A simple way to assist people to write their representatives is to connect to APF’s Online Advocacy Center.
https://secure2.convio.net/apf/site/Advocacy?pagename=homepage&page=UserAction&id=155&JServSessionIdr002=6ketk6ols1.app14a

Go to www.painfoundation.org and click on Take Action Now!
It is vitally important to impress upon our elected officials that they can make a difference in the lives of millions of their constituents who are currently suffering unnecessarily.

There is strength in numbers! RSDSA, RSDHope & For Grace have endorsed HR 1020. Thank you for being part of this united effort to Eliminate the Undertreatment of Pain!

22.5.06

Survey - Opiod Awareness

SURVEY OF WI PHYSICIANS SHOWS LACK OF KNOWLEDGE ABOUT OPIOIDS

University of Wisconsin School of Medicine and Public Health, Madison, WI

Opioid analgesics are the drugs of choice for the treatment of moderate to severe acute and cancer pain. Although their role in the management of chronic pain not related to cancer is controversial, there is increasing evidence for their benefit in certain patient populations.

Previous studies have shown that physicians hold many misconceptions about these drugs and about the laws and regulations that govern their use. Furthermore, the increase in the abuse of these medicines has added to the uncertainty about the appropriateness of using them for the treatment of chronic pain.

A 32-item survey to assess Wisconsin physicians' knowledge and attitudes toward opioid analgesic use was mailed to 600 randomly selected licensed physicians. The response rate was 37%. Half of
the respondents considered diversion a moderate or severe problem in Wisconsin. A majority considered addiction to be a combination of physiological and behavioral characteristics, rather than defining it solely as a behavioral syndrome. Most physicians felt it lawful and acceptable medical practice to prescribe opioids for chronic cancer pain, but only half held this view if the pain was not related to cancer.

Fewer physicians believed it lawful and generally accepted medical practice if the patient had a history of substance abuse. About two-thirds of physicians were not concerned about being investigated for their opioid prescribing practices, but some admitted that fear of investigation led them to lower the dose prescribed, limit the number of refills, or prescribe a Schedule III or IV rather than a Schedule II opioid. Wisconsin physicians who responded to this survey held many misconceptions about the prescribing of opioids. Such views coupled with a lack of knowledge about laws and regulations governing the prescribing of controlled substances may result in inadequate prescribing of these drugs with resultant inadequate management of pain.

Abstract 996, Journal of Pain, vol. 7, number 4, supp 2, April 2006
http://www.aacpi.wisc.edu/

Curb Drug Abuse

RX MONITORING PROGRAMS INEFFECTIVE IN CURBING DRUG ABUSE

Robert Twillman, PhD, immediate past-chair of the AACPI’s Advisory Council, head of the Kansas Pain Initiative, and program director of pain management at the University of Kansas Hospital, recently studied the effects of prescription monitoring programs (PMPs) on retail drug distribution patterns and measures of substance abuse. Twenty-two states currently have a system that tracks the prescribing of controlled substances.

Dr. Twillman presented his findings at the annual meeting of the American Pain Society earlier this month. His evaluation indicates that 1) states with PMPs, compared to those without PMPs, report less prescribing of most C-II opioids, especially morphine and oxycodone, while they report significantly greater prescribing of C-III opioids; and 2) states with PMPs do not report lower rates of abuse of prescription opioids, but in fact, actually report higher rates on one measure of such abuse.

When dividing states according to the type of PMP, those with PMPs that monitor both C-II and C-III opioids do not differ significantly from states with no PMPs in prescribing of any opioid except hydrocodone (with PMP states prescribing 68% more hydrocodone than states without PMPs). The pattern of findings with respect to drug abuse holds for these states. States that monitor only C-II opioids report significantly less prescribing of morphine, oxycodone, and hydrocodone, compared to states that monitor both C-II and C-III opioids.

This study suggests that PMPs are not effective in reducing drug abuse (and by extension, probably not effective in reducing drug diversion), and depending on the schedules monitored by the PMP, may result in "downscheduling" of medications prescribed to patients and in a sharp increase in prescribing of hydrocodone (which is the most commonly abused prescription opioid).

You can view Dr. Twillman’s presentation on the AACPI website at: http://aacpi.wisc.edu/policy.htm

19.5.06

RSD in Women

Chronic Pain Syndrome Hits Women Harder

Jennifer Wider, M.D.

Society for Women’s Health Research

If you’ve ever been in pain, you know it isn’t easy. Sometimes it can place serious obstacles in your path. But for hundreds of thousands of Americans, mostly women, who suffer from a chronic pain syndrome known as reflex sympathetic dystrophy syndrome (RSD), the pain can be constant and excruciating, making it difficult to even get through the day.

For Tracy Zuckerman who currently resides in Florida, the pain was disproportionate to her injuries. Years ago, she was in a head-on collision and the air bag in her car crushed her left hand and the right-side of her jaw. When her healing time was abnormally prolonged, it became quite clear that something else was wrong. Despite the fact that her hand wasn’t broken, the swelling was so severe that she couldn’t open it.

"My hand was not healing, it was swollen and discolored," Zuckerman said. "Someone would brush by me, barely touch me, and I’d have severe pain. I consider myself lucky because my orthopedic surgeon, who had seen a case in medical school, diagnosed me early on with complex regional pain syndrome."

Sometimes called complex regional pain syndrome (CRPS), RSD results when the nervous system doesn’t function properly. Instead, the nerves send incessant pain signals to the brain and the body reacts accordingly. It usually occurs as a response to a traumatizing incident such as an accident or surgical procedure. Like other chronic pain syndromes, RSD is more common in women.

"Epidemiological studies, and a recent web-based survey that we conducted, indicate that CRPS is more common in women than men," said Srinivasa Raja, M.D., director of the pain medicine division and director of pain research at Johns Hopkins University in Baltimore, Md. "The reason for this gender difference in the prevalence of CRPS is not clear. Such a female preponderance is, however, not unique to CRPS as other chronic pain states are also more frequently observed in females compared to males."

An early diagnosis and aggressive therapy are vital for healing and proper function. Unfortunately, diagnosing RSD can be difficult, because many people and members of the medical community are not familiar with the symptoms. According to the Reflex Sympathetic Dystrophy Syndrome Association in Milford, Conn., patients with this disorder see at least five doctors before receiving a proper diagnosis.

Zuckerman began treatment right away but it took a long time to find the right combination of therapies that worked.

"I tried many different treatments for several years," Zuckerman said. Her treatments included massage therapy, physical and occupational therapy, acupuncture and nerve blocks. "Everything is a combination," Zuckerman said. "It required a multi-disciplinary approach. I developed my own team to support me and guide me through this process, which include doctors and therapists. When it stops working, we change the approach. It’s a lot like cross training."

Echoing Zuckerman’s sentiments, Raja said "optimal treatment of this condition often requires a multi-disciplinary approach that includes physical therapy, diagnostic and or therapeutic nerve blocks and psychological consultations."

Zuckerman has learned to live with her condition, but getting well became a full-time job. "You cannot will yourself to be well," she said. "You need a team of doctors, nurses and a support group. It’s not about just taking a pill. You need to become an advocate for your own body."

New treatments are on the horizon for RSD.

"In recent years, spinal cord stimulation has shown promise as a treatment modality for cases that have not been treated successfully with conservative measures," Raja said. In addition, several academic centers have been studying the potential role of ketamine, a drug that can potentially reduce the heightened sensitivity of brain cells. More research involving ketamine is needed to make conclusions about the long-term benefits.

18.5.06

Canada RSD Network

The Canadian RSD Network will be hosting our Annual General Meeting and Conference on July 21, 2006 in British Columbia.

We have several guest speakers for this event. Seating is limited and we request people reserve a seat in advance.

This event is free.

Please RSVP 604-505-2934
or
info@canadianrsd.com
Agenda, guest speakers and more will be posted soon at: www.canadianrsd.com

July is RSD/CRPS Awareness Month in Canada!

17.5.06

Pain Control - RSD/Fibromyalgia - Allentown, PA

Lehigh Valley RSD/CRPS Friends of Hope

Presents

Eric Ratner M.D.
(Pain Management/Anesthesiology)

Saturday, June 3rd, 2006

Sacred Heart Hospital
4th and Chew Streets
Allentown, PA

2nd Floor Conference Center, Reception Rooms A-D

1:00 to 3:00 P.M. promptly

FREE for all attendees

Topic:
Medical Options for Pain Control for RSD/CRPS and Post-trauma Fibromyalgia

Dr. Eric Ratner, formerly of the Jefferson Pain Clinic, is the Medical Director of Pain Care Institute in Reading, PA. He is certified with the Board of Anesthesiology and has additional certifications in pain management. Dr. Ratner will discuss procedures such as epidural steroid-nerve blocks, stellate ganglion nerve blocks, and lumbar sympathetic nerve blocks as adjunctive medical therapies for RSD/CRPS.

Other pain management therapies will also be discussed. Family, friends, and medical professionals are welcome to join us! There will be an open question and answer session after the presentation.

This meeting is open to all those who suffer from chronic pain and our support group supports those specifically with Reflex Sympathetic Dystrophy/Complex Regional Pain Syndrome and Post trauma Fibromyalgia

For more information call our Info Line at 610-776-5992

15.5.06

Pain Article NY Times Magazine

My Pain, My Brain

5/14/06

Who hasn't wished she could watch her brain at work and make changes to it, the way a painter steps back from a painting, studies it and decides to make the sky a different hue? If only we could spell-check our brain like a text, or reprogram it like a computer to eliminate glitches like pain, depression and learning disabilities. Would we one day become completely transparent to ourselves, and - fully conscious of consciousness - consciously create ourselves as we like?

The glitch I'd like to program out of my brain is chronic pain. For the past 10 years, I have been suffering from an arthritic condition that causes chronic pain in my neck that radiates into the right side of my face and right shoulder and arm. Sometimes I picture the pain - soggy, moldy, dark or perhaps ashy, like those alarming pictures of smokers' lungs. Wherever the pain is located, it must look awful by now, after a decade of dominating my brain. I'd like to replace my forehead with a Plexiglas window, set up a camera and film my brain and (since this is my brain, I'm the director) redirect it. Cut. Those areas that are generating pain - cool it. Those areas that are supposed to be alleviating pain - hello? I need you! Down-regulate pain-perception circuitry, as scientists say. Up-regulate pain-modulation circuitry. Now.

Recently, I had a glimpse of what that reprogramming would look like. I was lying on my back in a large white plastic f.M.R.I. machine that uses ingenious new software, peering up through 3-D goggles at a small screen. I was experiencing a clinical demonstration of a new technology - real-time functional neuroimaging - used in a Stanford University study, now in its second phase, that allows subjects to see their own brain activity while feeling pain and to try to change that brain activity to control their pain.

Over six sessions, volunteers are being asked to try to increase and decrease their pain while watching the activation of a part of their brain involved in pain perception and modulation. This real-time imaging lets them assess how well they are succeeding. Dr. Sean Mackey, the study's senior investigator and the director of the Neuroimaging and Pain Lab at Stanford, explained that the results of the study's first phase, which were recently published in the prestigious Proceedings of the National Academy of Sciences, showed that while looking at the brain, subjects can learn to control its activation in a way that regulates their pain. While this may be likened to biofeedback, traditional biofeedback provides indirect measures of brain activity through information about heart rate, skin temperature and other autonomic functions, or even EEG waves. Mackey's approach allows subjects to interact with the brain itself.

"It is the mind-body problem - right there on the screen," one of Mackey's collaborators, Christopher deCharms, a neurophysiologist and a principal investigator of the study, told me later. "We are doing something that people have wanted to do for thousands of years. Descartes said, 'I think, therefore I am.' Now we're watching that process as it unfolds."

Suddenly, the machine made a deep rattling sound, and an image flickered before me: my brain. I am looking at my own brain, as it thinks my own thoughts, including these thoughts.

How does it work? I want to ask. Just as people were once puzzled by Freud's talking cure (how does describing problems solve them?), the Stanford study makes us wonder: How can one part of our brain control another by looking at it? Who is the "me" controlling my brain, then? It seems to deepen the mind-body problem, widening the old Cartesian divide by splitting the self into subject and agent.

But most of all I want to know: Will I be able to learn it?

For most of history, the idea of watching the mind at work was as fantastical as documenting a ghost. You could break into the haunted house - slice the brain open - but all you would find would be the house itself, the brain's architecture, not its invisible occupant. Photographing it with X-rays resulted only in pictures of the shell of the house, the skull. The invention of the CT scan and magnetic resonance imaging (M.R.I.) were great advances because they reveal tissue as well as bones - the wallpaper as well as the walls - but the ghost still didn't show up. Consciousness remained elusive.

A newer form of M.R.I., functional magnetic resonance imaging (f.M.R.I.), used with increasingly sophisticated software, is accomplishing this, taking "movies" of brain activity. Researchers are able to watch the brain work, as the films show parts of the brain becoming active under various stimuli by detecting areas of increased blood flow connected with the faster firing of nerve cells. These films are difficult to read; researchers puzzle over the new images like Columbus staring at the gray shoreline, thinking, India? Most of the brain is uncharted, the nature of the terrain unclear. But the voyage has been made; the technology exists. Pain - a complex perception occupying the elusive space spanning sensation, emotion and cognition - is a particularly promising area of imaging research because, researchers say, it has the potential to make great progress in a short time.

Perhaps more than any other aspect of human existence, persistent pain is experienced as something we cannot control but desperately wish we could. Acute pain serves the evolutionary function of warning us of tissue damage, but chronic pain does nothing except undo us. Pain is the primary complaint that sends people to the doctor. Of the 50-odd million sufferers in the United States, half cannot get adequate relief from their chronic pain. Many do not even have a diagnosis.

Unlike acute pain, chronic pain is now thought to be a disease of the central nervous system that may or may not correlate with any tissue damage but involves an errant reprogramming in the brain and spinal cord. The brain can generate terrible pain in a wound that is long healed, in a body that is numb and paralyzed or - in the case of phantom-limb pain - in a limb that no longer even exists.

Although there have been many theories about how pain works in the brain, it is only through neuroimaging that the process has actually been observed. It is now clear that there is no single pain center in the brain. Rather, pain is a complex, adaptive network involving 5 to 10 areas of the brain transmitting information back and forth.

This network has two pain systems: pain perception and pain modulation, which involve both overlapping and distinct brain structures. The pain-modulatory system constantly interacts with the pain-perception system, inhibiting its activity. Much chronic pain is thought to involve either an overactive pain-perception circuit or an underactive pain-modulation circuit.

Like everyone who suffers from chronic pain, I find it hard to believe that I have a pain-modulation circuit. The aspect of my pain I feel most certain about is that it is not voluntary: I cannot modulate it. And this belief is reinforced every single day that I suffer from pain, which is every day. Yet I know that pain is not a fact, like a broken bone; it's a perception, like hunger, about a physical state ("an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage," as the International Association for the Study of Pain defines it). And it's a mercurial perception; under certain circumstances the pain-modulatory system works like a spell and the brain completely blocks out pain.

Soldiers, athletes, martyrs and pilgrims engage in battles, athletic feats or acts of devotion without being distracted by the pain of injuries. When the teenage surfer Bethany Hamilton's arm was bitten off by a shark, she felt pressure, but "I didn't feel any pain - I'm really lucky, because if I felt pain, things might not have gone as well," she said (articulating one reason the modulatory system evolved: if she had thrashed about in pain, she would have bled until she drowned).

In addition to being activated by stress, the pain-modulatory system is triggered by belief. The brain will shut down pain if it believes it has been given pain relief, even when it hasn't (the placebo effect), and it will augment pain if it believes you are being hurt, even if you aren't (the nocebo effect). The brain's modulatory system relies on endogenous endorphins, its own opiatelike substances. The nature of a placebo has long been a source of speculation and debate, but neuroimaging studies have shown the way a placebo actually helps to activate the pain-modulatory system.

In a recently published study led by Dr. Jon-Kar Zubieta at the University of Michigan Medical School, the brains of 14 men were imaged after a stinging saltwater solution was injected into their jaws. They were then each given a placebo and told that it would positively relieve their pain. The men immediately felt better - and the screen showed how. Parts of the brain that release endogenous opiates lighted up. In other words, fake opiates caused the brain to dispense real ones. Like some New Age dictum, philosophy becomes chemistry; believing becomes reality; the mind unites with the body.

Other studies have shown that opiates and other medications rely on a placebo to achieve part of their effect. When subjects are covertly given strong opiates like morphine, they don't work nearly as well as they do if the subjects are told they are being given a powerful pain reliever. Even real medications require some of the brain's own bounty.

Conversely, thinking about pain creates pain. In studies at Oxford University, Irene Tracey has shown that asking subjects to think about their chronic pain, for example, increases activation in their pain-perception circuits. Distraction, on the other hand, is a great analgesic; when Tracey's volunteers were asked to engage in a complicated counting task while being subjected to a painful heat stimulus, she could watch the pain-perception matrix decrease while cognitive parts of the brain involved in counting lighted up. At McGill University, Catherine Bushnell has shown that simply listening to tones while being subjected to a heat stimulus decreased activity in the pain-perception circuit.

"There is an interesting irony to pain," comments Christopher deCharms, who worked with Mackey designing and carrying out the Stanford study. We were talking in his office at Omneuron, a Menlo Park medical-technology company he founded three years ago to develop clinical applications of neuroimaging. "Everyone is born with a system designed to turn off pain. There isn't an obvious mechanism to turn off other diseases like Parkinson's. With pain, the system is there, but we don't have control over the dial."

The goal of the Stanford technique is to teach people to control their dials - to activate their modulatory systems without requiring the extreme stress of fleeing from a shark or the deception of a placebo. The hope of neuroimaging therapy (as deCharms calls the Stanford technique) is that repeated practice will strengthen and eventually change the ineffective modulatory system to eliminate chronic pain, the way long-term physical therapy can change muscular weakness. The scan would thus be more than a research tool: the scan itself would be the treatment, and the subject his or her own researcher.

Only once do I recall having a glimmer of my own pain-modulatory system at work: a hidden power that emerged, dispensed with pain and then returned to some forgotten fold in my brain, where I have never been able to locate it again. The event did not take place on a battlefield or a marathon course or in a temple; it was in a basement of the Stanford University medical center three years ago. At the time, Mackey had designed an earlier study that did not use imaging technology but focused on how suggestion alters pain perception. Although I was not formally enrolled in the study, I asked if I could undergo a clinical demonstration. My experience illustrated the power of suggestion in an unexpected fashion.

A metal probe attached to the underbelly of my arm heated up and cooled down at set intervals. I was told that although the heat probe would feel uncomfortable, my skin would not be burned. During one exposure, I was instructed to think of the pain as positively as possible, during another to think of it as negatively. After each sequence, I was asked to rate my pain on a 0-to-10 scale, with 10 being the worst pain I could imagine.

Although I discovered that I could make the pain fluctuate depending on whether I was imagining that I was sunbathing or was the victim of an inquisition, I still rated all the pain as low - ranging from a 1 to a 3. If 10 was being slowly burned alive, I felt I should at least be begging for mercy to justify a rating of 5. So I insisted that Mackey turn up the dial so I could get a real response. But even during the moments when I was actively trying to imagine the pain as negatively as possible, it remained in a mental box of "not even burned," which kept it from really hurting: hurting, that is, the way a burn would.

As it turned out, I got a second-degree burn that later darkened into a square mark. Mackey was more than a little dismayed as we watched the reddening skin pucker, but I was thrilled. Naturally the protocol had been carefully designed not to injure anyone, yet in my case that protection had failed because of the very phenomenon it was designed to study: expectation - the effect of the mind on pain or placebo.

I had recently spent several weeks observing Mackey in the university's pain clinic, where he is associate director. I was so convinced that Mackey - then a tall sandy-haired 39-year-old with a deep interest in technology (he got a Ph.D. in electrical engineering before he went to medical school) and an air of radiant integrity - would not burn me that my brain had not perceived the stimulus as a threat and generated pain. I admired him, I trusted him, I was positive that he wouldn't hurt me. And, ipso facto, he hadn't.

Mackey's genius as a practitioner, I thought, lay partly in his ability to similarly inspire patients. "When I started working with pain patients, I realized how much of the treatment involved trying to reverse learned helplessness," he said - to rally them out of the despair ingrained from years of unremitting pain and cajole their minds to chip in its own analgesic to their therapies. "The purpose of this study is to show patients their mind matters," Mackey said.

The mark of the burn is barely visible now, but for a couple of years afterward, at times when my chronic pain was making me miserable, the sight of it would both encourage and reproach me. Here is the ultimate proof that my mind can control pain, I would think, yet I didn't know how to make it wake up and do so. I could take the edge off the pain by conjuring positive images, but the effects didn't last, and I never again had the remarkable placebo response that masked a second-degree burn. In fact, a mild burn from spilling tea on my hand one day brought tears to my eyes.

When the real-time neuroimaging study began, I couldn't wait to try it.

The area of the brain that the scanner focuses on is the rostral anterior cingulate cortex (rACC). The rACC (a quarter-size patch in the middle-front of the brain, the cingular cortex) plays a critical role in the awareness of the nastiness of pain: the feeling of dislike for it, a loathing so intense that you are immediately compelled to try to make it stop. Indeed, the pain of pain, you might say, its defining element, is the way in which the sensation is suffused with a particular unpleasantness researchers refer to as dysphoria. Since pain is a perception, it's not pain if you don't experience it as hurting. You can feel hot or cold or pressure, and note them simply as stimuli, but when they exceed a certain intensity, the rACC kicks in, and suddenly they become painful, riveting your attention and causing you to recoil.

Many pain-reducing techniques aim to manipulate the conscious awareness of pain. Distraction, placebo, meditation, imagining pleasant scenes and hypnosis all result in a reduction of rACC activation when they work. Patients who have undergone a radical surgical treatment occasionally used for pain (as well as for mental illness) called a cingulotomy, in which the rACC is partly destroyed, report that they are still aware of pain but that they don't "mind" it anymore. Their emotional response has receded.

The image I saw while lying in the f.M.R.I. machine at the time of the recent Stanford study was not literally my rACC but a visual analogue of it that is easier to see: a 3-D image of a fire. The flames represent the degree of activation in your rACC: when it is low, the flames are low; when rACC activation is high, the flames flare. The study involves five 13-minute scanning runs, each consisting of five cycles of a 30-second rest followed by a 1-minute interval in which you try to increase rACC activation and then a 1-minute interval in which you try to decrease rACC activation.

Before my scan began, I was prepped in different mental strategies for increasing and modulating my pain. Everyone's brain works a bit differently, though, so subjects have to experiment in the scanner to see what is most effective for them. For some, trying to distract themselves from their pain works best; for others, focusing on their pain - like embracing a Zen koan - seems to be what triggers their pain-modulatory system. When deCharms used neuroimaging therapy on himself to try to alleviate his chronic neck pain, he concentrated on the pain itself and felt it "suddenly melt away." He said that a patient described the feeling as being "like a runner's high" (a state that has been shown to involve the release of endogenous endorphins).

Increase Your Pain, the screen commanded, as the first run began. I tried to recall the mental strategies in which I had been prepped for increasing pain: Dwell on how hopeless, depressed or lonely you felt when your pain was most severe. Sense that the pain is causing long-term damage.

Dwelling on the hopeless loneliness of my pain certainly made the flames of my rACC spark. The mental image that I found increased my pain the most, however, was the one that matched the visual analogue of the rACC: Picture a hot flame on your painful area. Try to make the flame grow in the painful area, and imagine it actually burning your flesh.

Having recently read Ariel Glucklich's extraordinary "Sacred Pain," I had plenty of details of the burning of heretics and witches available to me. I had only to imagine the smell of sizzling hair to make the flames of my rACC explode.

Decrease Pain, the screen commanded.

The suggested pain-reduction strategies, however, did little to quell the flames on the screen. I pictured suffocating the pain with banal positive imagery: flowing water or honey, something soft and gentle, but my mind kept slipping back to the progress of the auto-da-fé, and the rACC fire flared.

Feel that sensation, but tell yourself that it is just a completely harmless, short-term tactile sensation.

Pilgrims and devotees all around the world choose to inflict pain upon themselves during sacred rites - from being nailed to crosses to dangling from hooks. For them, pain is an occasion for euphoria, not dysphoria. There are many historical records of the equanimity saints and martyrs often possessed during torture. The second-century Jewish martyr Rabbi Akiva, for example, continued to recite a prayer with a smile on his lips while the flesh was being combed from his bones. "All my life," he explained to the puzzled Roman general orchestrating his execution, "when I said the words 'You shall love the Lord your God with all your heart, with all your soul, and with all your might,' I was saddened, for I thought, When shall I be able to fulfill this command? Now that I am giving my life and my resolution remains firm, should I not smile?"

As Glucklich writes, the conviction that pain is a spiritual opportunity seems paradoxically anesthetizing - or, as a scientist would say, religious states of conviction can robustly activate the pain-modulatory system.

During my next Decrease Pain interval, instead of trying to picture a vacation, I imagined myself as a martyr, lucidly reciting Though I walk through the valley of the shadow of death while being burned at the stake. My rACC activation - I noted - respectfully quieted. Then I remembered that the 23rd Psalm seems to have Christian associations, and since I was presumably being tortured for being half-Jewish, a Jewish prayer might be more appropriate. Unless, that is, I was being accused of witchcraft, in which case, I might be generally disillusioned with Judeo-Christian prayer. As I tried to settle on a fantasy, I noticed that my rACC stayed low: Irene Tracey's theory of the modulating effects of distraction. By the last run, I had the strategies down - heretic-martyr: rACC down; heretic-victim: rACC up.

The results of the scan, Mackey showed me, revealed significant brain control. A week later, I was scanned again, this time in the offices of Omneuron. I could feel that it was easier to control my rACC with less reliance on elaborate fantasy; I was interacting more directly with my brain.

This learning effect was clearly seen in the recent Stanford study (which was financed in part by the National Institutes of Health). The first phase of the study looked at 12 subjects with chronic pain and 36 healthy subjects. (The healthy participants were subjected to a painful heat stimulus in the scanner and tried to modulate their responses. The chronic-pain patients, however, simply worked to reduce their own pain.) The chronic-pain patients who underwent neuroimaging training reported an average decrease of 64 percent in pain rating by the end of the study. (Healthy subjects also reported a significant increase in their ability to control the pain.)

"One big concern we had, " Mackey says, "is, Were we creating the world's most expensive placebo?" To ensure against that, Mackey trained a control group in pain-reduction techniques without using the scanner (as in his previous study) to see if that was as effective as employing a $2 million machine. Mackey also tried scanning subjects without showing them their brain images or tricking subjects by feeding them images of irrelevant parts of the brain or feeding them someone else's brain images. "None of these worked," Mackey says, "or worked nearly as well." Traditional biofeedback also compared unfavorably; changes in pain ratings of subjects in the experimental group were three times as large as in the biofeedback control group.

The second phase of the study, which is now under way, is designed to assess whether neuroimaging therapy offers long-term practical benefits to a larger group of chronic-pain patients. After the six sessions designed to teach them to regulate their pain, they will be observed for at least six months. The idea is to see whether they can fundamentally change their modulation system so that it can reduce pain all the time without constantly and consciously thinking about it. If so, the technique would not simply provide shelter from the storm of pain; it would bring about climate change.

"I believe the technique may make lasting changes because the brain is a machine designed to learn," deCharms says. The brain is soft-wired (plastic) rather than hard-wired: whenever you learn something new, new neural connections are believed to form and old, unused ones to wither away. (Researchers refer to this as activity-dependent neuroplasticity.) In other words, if you actively engage a certain brain region, you can alter it.

Many diseases of the central nervous system involve inappropriate levels of activation in particular brain regions that change the way they operate (negative neuroplasticity). Some regions experience atrophy, while other regions become hyperactive. (For example, epilepsy involves hyperactivity of cells; stroke, Parkinson's and other diseases involve the atrophy of nerve cells.) With chronic pain, it is believed that additional nerve cells, recruited for transmitting pain, create more pain pathways in the nervous system, while nerve cells that normally inhibit or slow the signaling, decrease or change function.

In addition, chronic pain results in a significant loss of other kinds of brain cells. A. Vania Apkarian at Northwestern University found that while the brain of a healthy person shrinks 2.5 percent a year, in a person with chronic back pain, it shrinks an additional 1.3 percent annually in the areas that involve rational thinking. I know chronic pain interferes with my concentration at times, but I never imagined that it could be truly impairing it! The Stanford technique may mitigate this harm by teaching people how to increase the efficacy of the healthy cells.

Moreover, the technique may offer a particular advantage over drug therapy. It is very difficult to design drugs to fix a problem in a specific region of the brain because the receptors that drugs target, like the opiate receptors, generally appear in multiple systems throughout the brain (which is partly why drugs almost always have side-effects). Neuroimaging therapy, on the other hand, is designed to teach control of a localized brain region.

"The technique gives people a tool they didn't know they had," Mackey says, "cognitive control over neuroplasticity. We don't fully understand how this feedback mechanism is working, but it provides tangible evidence that people can change something in their own brains, which can be very empowering. It takes Buddhist monks 30 years of sitting on a mountain learning to control their brains through meditation - we're trying to jump-start that process." As to how exactly it works - how the decision-making parts of the brain (the prefrontal regions of the cortex) cause the change in the rACC - "Heck if I know!" he says. "How do we get the brain to do anything? We can map out the anatomical circuits involved and the general functions of those circuits, but we can't tell you the mechanism by which any cognitive decision is translated into action."

If neuroimaging therapy could treat pain, could it rewire the brain to fix other diseases, like depression, stroke and learning disabilities, or exercise the brain in ways that would make it cleverer and more adept at certain skills? Neuroimaging has shown, for example, that the part of the brains of London cabdrivers that regulates spatial relations is larger than usual and that learning to juggle creates visible changes in parts of the brain involved with motor coordination during three months of training. I'm constantly getting lost and dropping things. Could I exercise and strengthen those areas more quickly by, say, thinking about maps in the scanner than by driving around London?

"What is the limit to neuroimaging therapy?" deCharms muses. "Could you learn to target the reward or serotonin system and up-regulate happiness? Could you augment psychotherapy by allowing the patient and the therapist to watch the brain?" - an idea Omneuron is already exploring, by bringing therapists and patients to the scanner and imaging patients' brains as they undergo the sessions. "After all, talk therapy is about learning to understand thought processes - to understand neural substrates and change them," he says.

How deep can the insights that functional imaging might offer really go?

What I'd like to do most is not fix problems or improve skills but use imaging as a vehicle for self-transparency. Instead of puzzling about my motivations, I'd like to be able to read my mind completely, like a book: for imaging to be the Plexiglas window through which I could finally see the ghost.

"Hmm," Dr. Scott Fishman, chief of the pain-medicine division at the University of California, Davis, said dubiously when I brought up this notion. "I'm not sure that functional imaging is actually looking at the mind. The mind is like a virtual organ - it doesn't have a physical address that we know about. Functional imaging provides a two-dimensional snapshot of a three-dimensional or a four-dimensional event of this entity of the mind. Right now, imaging is just looking at the brain; we have to be honest about that." Imaging shows the level of activation of different parts of the brain, from which we can extrapolate something about the mind, he points out, "but what we really need to see is how the parts talk to each other - and the complex nuances of their language."

The brain has more than a hundred billion neurons. All functional imaging can tell us now is that a few hundred million of them in various areas become more active at certain times. It's as if you were trying to conduct a symphony by watching a silent film of the concert. You would see the players in the bass section active at one moment, vigorously gesturing, and then the rest of the orchestra would join in, but you couldn't hear the notes or how they form strands of melody and harmony and meld together to create the ethereal experience.

"Consciousness is not neurons firing - consciousness is a transcendent emergent phenomenon that depends on the firing of neurons," says Dr. Daniel Carr, an eminent pain researcher who is now the C.E.O. of Javelin Pharmaceuticals. "The gears of a watch rotate and keep time, but the turning of the gears is not time. The question is, Is neuroimaging a picture of the experience of consciousness or is it a picture of a mechanism associated with that experience? Can there actually be a picture of an experience? Does a picture of a funeral or a wedding show you experiences? Or is there an unbridgeable gap there because you need to already understand the experience in order to interpret the photos? If a higher being told us how consciousness works, could we understand the explanation?"

Melanie Thernstrom is a contributing writer for the magazine. She is working on a book about pain.

14.5.06

Save the Date - Chicago Conference, 9/8/06

A Comprehensive Review of Chronic Regional Pain Syndrome - Dispelling the Myths and Looking at Emergent Treatment

When: September 8, 2006

Where: Northwestern Memorial Hospital
Conference Center
3rd Floor
201 East Huron
Chicago, IL 60611

Co-directors: R. Norman Harden, MD, Director, Center for Pain Studies, Addison Chair, Rehabilitation Institute of Chicago, Chicago, IL

Joshua P. Prager, MD, MS, Director, Center for the Rehabilitation of Pain Syndromes , Departments of Internal Medicine and Anesthesiology, David Geffen School of Medicine at UCLA, Los Angeles, CA

Presented by: The Reflex Sympathetic Dystrophy Syndrome Association
The Rehabilitation Institute of Chicago

http://rsds.org/4/resources/chicago_conference.htm

10.5.06

New Clinical Drug Trial - New York

Beth Israel's Institutional Review Board has approved an addendum to the original study to allow people with CRPS who are in the Workers Compensation system to participate in the study (if you meet study's inclusion criteria).

RSD/CRPS (COMPLEX REGIONAL PAIN SYNDROME) NEW CLINICAL DRUG TRIAL

If you have received a diagnosis of RSD or CRPS, you may be eligible to participate in a study of a potentially new treatment.

To assess your study eligibility, you will be asked the following questions regarding your painful limb:
o Have you had continuing pain for at least one month?
o Have you experienced increased skin sensitivity to touch or clothing?
o Has your skin felt especially cold or especially warm?
o Has the skin color changed?
o Has there been swelling or unusual sweating?
o Has there been any impairment in the range of motion of your affected joints (eg, fingers, wrist, ankle, foot)?
o Has there been any abnormal change in the skin, nails or hair?

For more information, please contact:
Department of Pain Medicine and Palliative Care
Beth Israel Medical Center, NY
Call JE at 1-212-844-1829
Visit www.stoppain.org

8.5.06

Important Reference - NIH & RSD in Spanish

From the National Institutes of Health:
http://www.ninds.nih.gov/disorders/spanish/sindrome_de_dolor_regional_complejo.htm

Linking patients to medical research:
http://www.clinicaltrials.gov/ct/show/NCT00109772?order=2

3.5.06

May 15 Medicare Drug Benefit Deadline

Prescription Drug Coverage for People with Medicare: Enrollment Deadline of May 15 Rapidly Approaching

If you have Medicare whether because you are 65 or older or because you are considered disabled by Social Security you can now get prescription drug coverage through Medicare.

However, you may be better off not joining a Medicare plan if you already have other drug coverage that is as good or better than a Medicare plan (creditable coverage). If you have prescription drug coverage now through a spouse, for example, or through a former employer, you should have received a letter telling you whether or not the coverage is creditable. If it is creditable, as long as you keep it, you do not have to think about Medicare enrollment deadlines. If it is not creditable or if you do not have any prescription drug coverage now, Medicare's prescription drug plans may benefit you.

Medicare's prescription drug coverage, known as Part D, is a voluntary or optional program. Hence, unless you have Medicaid and Medicare or unless you were in a Medicare Advantage plan with some drug coverage at the end of 2005, you must choose and enroll into a plan if you want the Part D coverage.

The enrollment deadline for 2006 is Monday, May 15. (If you applied for "extra help" or the low-income subsidy through the Social Security Administration or through your state's Medicaid office and did not enroll in a plan, you should have received a letter a few weeks ago telling you what plan you have as of May 1. If that plan does not cover your medications or if for any reason you do not like the plan, you should be able to switch plans at least once before May 15.)

Most people will pay a monthly premium for Part D (just as there is a premium for Medicare Part B which covers many out-patient services). Many people with low incomes and certain limited assets (like a savings accounts) can get help paying the costs of Part D.

There are also numerous plans with very low monthly premiums, though these are not always the best choice for people with high drug costs. There are many plans available around the country, and because there are so many plans with different costs and different lists of drugs covered (formularies) and different rules on prior authorization, quantity limits, and step therapy, it can be extremely difficult to choose a Part D plan that is right for you.

Moreover, under the law, Part D plans cannot cover certain categories of drugs, including the benzodiazepines that are sometimes used by people with RSD (such as clonazepam or Klonopin and alprazolam or Xanax). Yet if you have Medicare and no prescription drug coverage (or limited drug coverage, such as a standard Medigap prescription drug coverage plan), you may still find Part D valuable.

Just remember that if you already have prescription drug coverage that is as good or better than a Medicare plan (creditable coverage), including a retiree plan, signing up for Part D may mean that you and any of your dependents (such as a spouse or a child) on that policy can lose that entire health coverage permanently.

If you do not enroll in a Part D plan by May 15 and you do not now have other drug coverage that is as good or better than a Medicare plan (creditable coverage) and you cannot get a special enrollment period, you will not be able to get drug coverage through Medicare until January, 2007. In addition, the law says that you will pay a penalty higher Part D monthly premiums for as long as you have a Part D plan.

If you have any questions about Medicare's prescription drug coverage, you can contact Christin Engelhardt, who is working on health insurance issues for the RSDSA, at rsdsa-dc@hotmail.com.

1.5.06

AANP News Brief

Multicultural Pain Management

Health care professionals can benefit from understanding the diverse
cultural attitudes patients have toward pain and tolerance.


By Maureen Sullivan-Tevault, RN, CEN

Despite significant advances in many areas of medicine, many studies, including a landmark investigation of elderly cancer patients and pain management published in JAMA in 1998, indicate pain remains poorly managed and under-treated for many patients.1 Unrelieved pain has been associated with undesirable outcomes, such as delays in postoperative recovery. Thus, health care providers must improve their understanding of pain management.

One of the most challenging aspects of pain management is understanding a patient's culture and how it affects their response to pain. Religious beliefs, cultural influences and diverse personal attitudes toward pain and suffering impact a person's response to pain, and health careproviders have a responsibility to honor their choices, offer them culturally competent care and maximize their pain relief options.

Patients need to be educated about the importance of adequate pain relief, be it delivered via traditional pain medications or, if the patient prefers, through alternative options, such as acupuncture, massage, imagery, meditation, music therapy, relaxation therapy, yoga or herbs.

JCAHO established standards related to pain management in 1999.2 These standards advocate the patient's right to appropriate management of pain and the provider's responsibility to educate patients and their families about the importance of pain management. Also noted in the standards is the need to ensure staff competency in both pain assessment and management to achieve optimal results for patients.

Demographics of Pain

Pediatric patients often are under-treated for pain because they cannot effectively communicate the level of pain they are experiencing. By age 4, however, most children can point to the part of their body causing them pain or identify it on a drawing.

While children's coping skills and developmental levels vary widely, their body language can provide clues to pain they are experiencing. For example, a child lying on his side in bed, with his knees pulled up toward his chest, might have abdominal pain.3

Elderly patients face unique issues regarding pain management, as well. For example, the desire to be a "good patient" often makes them hesitant to mention their pain. They also may fear the addiction potential and other side effects of narcotics. They may decline any pain medication, preferring to "tough it out."

Pain management for the elderly should focus on the different types of pain they suffer, including arthritis, osteoporosis, diabetes-related neuropathy and angina, to name a few examples. And these types of pain all may need to be addressed by different interventions. In addition, pain from different conditions, such as arthritis, may vary throughout the day and depend on activity levels, and can require multiple medications.

Meanwhile, cancer-related pain is another specialized area of pain management. These patients may fear increasing medication amounts can cause side effects worse than the pain, prolong hospitalization and hasten death. Education of staff and patients and their families about cancer pain management is paramount, to not only reduce suffering, but also promote healing.4

Cultural Influences

The influence of cultural upbringing impacts the response to pain, as
well as acceptance of pain medication.

While health care providers cannot know everything about a person's culture, they should be aware of external influences to one's pain experience, including the effects of religious beliefs. They should acknowledge and respect the patient's choices in pain management. In some cultures, pain may be interpreted as a test of one's faith, and the foregoing of pain medication may be viewed as a sign of personal strength and fortitude.

To maintain open, accepting lines of communication, the health care provider should acknowledge and respect a patient's choice to decline pain medication. The provider may enlist chaplain services and educate the patient of various other treatment options that may reduce pain, such as massage, relaxation and even biofeedback. The provider also may offer to pray with the patient, further developing a sense of trust and acceptance.

Life Experience

Pain is a complex phenomenon. A person's response is shaped by his individual life experiences. The health care provider first must understand the patient's pain is unique, and also be aware no two people will respond to pain in precisely the same manner.

Patient education is important to ensure patients receive sufficient pain control to optimize recovery and enhance their quality of life. Patients' family members also should be educated regarding adequate pain management in regard to its positive influence in the healing process.
Many patients, hesitant to ask for "as needed" medications for fear of appearing weak, may respond better to scheduled analgesic administration.

The effective management of pain is multifaceted at best. To maximize patient comfort and trust and to minimize poor outcomes, the health care provider must take into account not only the patient's complaints of pain, but factors influencing the patient's response to it. A willingness to understand the uniqueness of the patient's pain and to respect the patient's pain management choices will greatly improve the success of any interventions.

References

1. Bernabei, R., et al. (1998). Management of pain in elderly patients
with cancer. JAMA, 279(23), 1877-1882.

2. JCAHO. (1999, August 3). Joint Commission focuses on pain
management. Retrieved Feb. 12, 2005 from the World Wide Web:
http://www.jcaho.org/

3. Wong, D.L., & Hockenberry-Eaton, M. (2001). Wong's essentials of
pediatric nursing (6th ed.). St. Louis: Mosby.

4. National Coalition for Cancer Survivorship. (2004). Pain and the
elderly. Retrieved June 13, 2005 from the World Wide Web:
http://www.canceradvocacy.org/resources/essential/pain/elderly_test.aspx

Maureen Sullivan-Tevault works in the pain management department at the VA Medical Center, Bay Pines, FL.